Related Experiment Video
Updated: May 22, 2026

Purification of Ubiquitinated p53 Proteins from Mammalian Cells
Published on: March 21, 2022
Aurora B kinase phosphorylates and instigates degradation of p53
Chris P Gully1, Guermarie Velazquez-Torres, Ji-Hyun Shin
1Graduate School of Biomedical Sciences, University of Texas, Houston, TX 77030, USA.
Abstract:
Aurora B is a mitotic checkpoint kinase that plays a pivotal role in the cell cycle, ensuring correct chromosome segregation and normal progression through mitosis. Aurora B is overexpressed in many types of human cancers, which has made it an attractive target for cancer therapies. Tumor suppressor p53 is a genome guardian and important negative regulator of the cell cycle. Whether Aurora B and p53 are coordinately regulated during the cell cycle is not known. We report that Aurora B directly interacts with p53 at different subcellular localizations and during different phases of the cell cycle (for instance, at the nucleus in interphase and the centromeres in prometaphase of mitosis). We show that Aurora B phosphorylates p53 at S183, T211, and S215 to accelerate the degradation of p53 through the polyubiquitination-proteasome pathway, thus functionally suppressing the expression of p53 target genes involved in cell cycle inhibition and apoptosis (e.g., p21 and PUMA). Pharmacologic inhibition of Aurora B in cancer cells with WT p53 increased p53 protein level and expression of p53 target genes to inhibit tumor growth. Together, these results define a mechanism of p53 inactivation during the cell cycle and imply that oncogenic hyperactivation or overexpression of Aurora B may compromise the tumor suppressor function of p53. We have elucidated the antineoplastic mechanism for Aurora B kinase inhibitors in cancer cells with WT p53.
Insights
Aurora B kinase phosphorylates tumor suppressor p53, accelerating its degradation and suppressing its cell cycle inhibition. Inhibiting Aurora B restores p53 function, offering a potential cancer therapy strategy.
Area of Science:
- Cell Biology
- Molecular Oncology
- Biochemistry
Background:
- Aurora B kinase is crucial for cell division and frequently overexpressed in cancers.
- Tumor suppressor p53 regulates the cell cycle and apoptosis.
- The relationship between Aurora B and p53 during the cell cycle was previously unknown.
Purpose of the Study:
- To investigate the interaction and regulation between Aurora B kinase and p53.
- To elucidate the mechanism by which Aurora B affects p53 function.
- To explore the therapeutic potential of targeting Aurora B in cancer cells with wild-type p53.
Main Methods:
- Co-immunoprecipitation to detect protein interactions.
- Western blotting to assess protein levels and phosphorylation.
- Ubiquitination assays to study protein degradation pathways.
- Cell-based assays to evaluate gene expression and cell proliferation.
Main Results:
- Aurora B directly interacts with p53 in the nucleus and at centromeres.
- Aurora B phosphorylates p53 at specific sites (S183, T211, S215), promoting its degradation via the ubiquitin-proteasome system.
- This phosphorylation suppresses the expression of p53 target genes involved in cell cycle arrest and apoptosis (e.g., p21, PUMA).
- Inhibition of Aurora B in cancer cells with wild-type p53 increased p53 levels and its target gene expression, leading to tumor growth inhibition.
Conclusions:
- Aurora B directly regulates p53 stability and function by promoting its degradation.
- Overexpression of Aurora B can inactivate the tumor suppressor function of p53.
- Targeting Aurora B kinase is a promising therapeutic strategy for cancers with wild-type p53.
Related Concept Videos
Abnormal Proliferation
PI3K/mTOR/AKT Signaling Pathway
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
The Intrinsic Apoptotic Pathway
Anaphase Promoting Complex

